Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Müller, H; Kniepeiss, D; Stauber, R; Schrem, H; Rauter, M; Krause, R; Schemmer, P.
Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.
Am J Transplant. 2020; [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
Kniepeiss Daniela
Krause Robert
Müller Helmut
Schemmer Peter
Schrem Harald Heinrich
Stauber Rudolf

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Immunosuppression and frequent comorbidities in transplant recipients potentially increase the risk of fatal outcomes of pandemic coronavirus disease 2019 (COVID-19) [1]. A 1965 born male had suffered from haemophilia A. In the nineteen-seventies, he acquired hepatitis C virus (HCV) infection, probably via factor VIII supplementation, and in 1985 human immunodeficiency virus (HIV) infection. Interferon-based HCV therapy resulted in a sustained virological response. Antiviral treatment with emtricitabine/tenofovir alafenamide/rilpivirin for HIV is ongoing since 2016. HIV suppression with repeatedly negative PCR results has been achieved. This article is protected by copyright. All rights reserved.

Find related publications in this database (Keywords)
clinical research
infection and infectious agents - viral
hepatitis C
infection and infectious agents - viral
human immunodeficiency virus (HIV)
acquired immunodeficiency syndrome (AIDS)
liver transplantation
organ transplantation in general
© Med Uni Graz Impressum